Screener / SEC EDGAR /CIK 0001609550 /10-K filed Feb 13, 2026, compared with Feb 10, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Medical Instruments

Inspire Medical Systems, Inc. INSP

Compare with peers Embed
Planned sales, announced before they happen

1 trading plan running, 8 Form 144 notices for $654K

10-Q, 10-K and Form 144

What INSP's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 31, 2023 to Apr 10, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
John Rondoni
Chief Product and Innovation Officer
Adopted 10b5-1 plan May 22, 2026 10-Q Aug 3, 2026
Shawn T McCormick
Director
Adopted 10b5-1 plan Aug 29, 2025 10-Q Nov 3, 2025
John Rondoni
Chief Product and Innovation Officer
Ended 10b5-1 plan May 13, 2025 10-Q Aug 4, 2025
Bryan Phillips
General Counsel
Adopted 10b5-1 plan Nov 27, 2024 10-K Feb 10, 2025
Randall Ban
EVP Patient Access and Therapy Development
Adopted 10b5-1 plan Nov 13, 2024 10-K Feb 10, 2025
Richard J. Buchholz
Chief Financial Officer
Adopted 10b5-1 plan Nov 13, 2024 10-K Feb 10, 2025
Shawn T McCormick
Director
Ended 10b5-1 plan Nov 1, 2024 10-K Feb 10, 2025
Georgia Melenikiotou
Director
Adopted 10b5-1 plan Aug 30, 2024 10-Q Nov 4, 2024
Shawn T McCormick
Director
Adopted 10b5-1 plan May 24, 2024 10-Q Aug 6, 2024
John C. Rondoni
Chief Technology Officer
Adopted 10b5-1 plan May 23, 2024 10-Q Aug 6, 2024
Randall A. Ban
Chief Commercial Officer
Adopted 10b5-1 plan May 16, 2024 10-Q Aug 6, 2024
Jerry Griffin, M.D.
Director
Ended 10b5-1 plan Nov 30, 2023 10-K Feb 9, 2024
John C. Rondoni
Chief Technology Officer
Ended 10b5-1 plan Nov 23, 2023 10-K Feb 9, 2024
Richard J. Buchholz
Chief Financial Officer
Adopted 10b5-1 plan Aug 31, 2023 10-Q Nov 7, 2023
Georgia Garinois-Melenikiotou
Director
Adopted plan Aug 29, 2023 10-Q Nov 7, 2023
Timothy P. Herbert
Chief Executive Officer
Adopted plan Aug 28, 2023 10-Q Nov 7, 2023
Steven Jandrich
Vice President, Human Resources
Adopted 10b5-1 plan Aug 17, 2023 10-Q Nov 7, 2023
Randall Ban
Chief Commercialization Officer
Adopted 10b5-1 plan Aug 15, 2023 10-Q Nov 7, 2023
Philip J. Ebeling
Chief Operating Officer
Adopted 10b5-1 plan Aug 10, 2023 10-Q Nov 7, 2023
John C. Rondoni
Chief Technology Officer
Adopted 10b5-1 plan May 19, 2023 10-Q Aug 1, 2023
Show the other 12 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Aug 24, 2026 JOHN RONDONI
Officer
64 $4K
Aug 7, 2026 JASON P KELLY
Officer
963 $57K
May 15, 2026 JOHN RONDONI
Officer
2,641 $114K
May 14, 2026 JOHN RONDONI
Officer
700 $30K
May 8, 2026 SHAWN T MCCORMICK
Director
696 $32K
Jan 9, 2026 JOHN RONDONI
Officer
109 $10K
Dec 2, 2025 SHAWN T MCCORMICK
Director
1,200 $152K
Nov 28, 2025 SHAWN T MCCORMICK
Director
2,000 $255K

From the Form 144 XML filed with the SEC, since Nov 28, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INSP/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.